Orphenadrine Citrate Extended-Release Tablets, USP 100 mg, Rx Only, 100 Tablets, Manufactured by Sandoz Inc., Princeton, NJ 08540…
Reason CGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily limit.
5 FDA recalls mention Orphenadrine. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Orphenadrine.
Reason CGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily limit.
Reason Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific…
Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they…
Reason Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.
Reason Labeling: Label Mixup; ORPHENADRINE CITRATE ER Tablet, 100 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC…
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.